| [1] |
Schlumberger M, Sherman SI. Approach to the patient with advanced differentiated thyroid cancer[J].Eur J Endocrinol, 20 12,166(1):5-11.
|
| [2] |
Toniato A,Boschin I,Casara D,et al. Papillary thyroid carcinoma: factors infl uencing recurrence and survival[J]. Ann Surg Oncol, 20 08,15(5):1518-22.
|
| [3] |
Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret protooncogene rearrangements, in thyroid tumors from patients who had received external radiation[J]. Oncogene， 19 97, 15(11):1263-73.
|
| [4] |
Apel RL, Alpert LC, Rizzo A, et al. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components[J]. Arch Pathol Lab Med ,1994,118(11):1143-7.
|
| [5] |
Sadow PM, Hunt JL. Mixed medullary-follicular-derived carcinomasof the thyroid gland[J]. Adv Anat Pathol,2010,17(4): 28 2-5.
|
| [6] |
Volante M, Papotti M, Roth J, et al. Mixed medullary-follicular thyroid carcinoma,Molecular evidence for a dual origin of tumor components[J].Am J Pathol,1999,155(5):1499-509.
|
| [7] |
Rossi S, Fugazzola L, De Pasquale L, et al. Medullary and papillarycarcinoma of the thyroid gland occurring as a collision tumour:report of three cases with molecular analysis and review of the literature[J]. Endocr Relat Cancer,2005,12(2):281-9.
|
| [8] |
Lundgren CI,Delbridg L,Learoyd D,et al.Surgical approach to medullary thyoid canner[J].Arq Bras Endocrinol Metabol,2007,51 (5) :818-24.
|
| [9] |
Gong L,Yi CH,Chen WK,et al. Retrospective Analysis of Pattern of Cervical Lymph Node Metastasis in Differentiated Thyroid Carcinoma[J].Zhong Liu Fang Zhi Yan Jiu,2012,39(1):48-50.[龚 龙,易春华,陈文奎,等.分化型甲状腺癌颈淋巴结转移特点的回 顾性分析[J].肿瘤防治研究,2012,39(1):48-50.]
|
| [10] |
Moo-Young TA,Traugott AL,Moley JF.Sporadic and familial medullary thyroid carcinoma:state of the art[J]. Surg Clin North Am,2009,89 (5):1193-204.
|
| [11] |
Zhang ZX, Li ZJ,Tang PZ, et al. Surgical treatment and prognosis analysis On medullary thyroid carcinoma[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2011,46(3):209-13.[张再兴，李正 江，唐平章，等.甲状腺髓样癌的外科治疗及预后分析[J].中华 耳鼻咽喉头颈外科杂志,2011,46(3):209-13.]
|
| [12] |
Wang JF, Zhang HM, Xu JP, et al. Value of ultrasonography and 99 mTcO4 imaging in diagnosing thyroid nodules[J]. Jiangsu Yi Yao,2011,37(17):2011-3. [王济芳,张海鸣,许建萍,等.B超、 99 mTcO4显像和细针穿刺活检对甲状腺结节的诊断价值[J].江 苏医药,2011,37(17):2011-3.]
|
| [13] |
Takami H, Ito Y, Okamoto T, et al.Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese society of thyroid surgeons and Japanese association of endocrine surgeons[J].World J Surg ,2011,35(1):111-21.
|
| [14] |
Chen JC, Li C, Wang SX, et al. Guidelines for the diagnosis and treatment of differentiated thyroid carcinoma[J].Zhong Liu Yu Fang Yu Zhi Liao,2011,24(1):55-68. [陈建超,李超, 王少新,等.分化型甲状腺癌的诊治指南[J].肿瘤预防与治 疗,2011,24(1):55-68.]
|
| [15] |
NCCN clinical practice guidelines in thyroid carcinoma[S]. Version 1. 2011.
|
下载:
